Labcorp to Announce First Quarter Financial Results on April 30, 2026
Rhea-AI Summary
Labcorp (NYSE: LH) will report first-quarter 2026 financial results before the market opens on April 30, 2026. A live webcast will begin at 9:00 a.m. ET the same day to discuss results. The earnings release and financial information will be posted on the investor relations website.
A replay will be posted approximately two hours after the live event and will remain available for one year on the site's News & Events section.
Positive
- None.
Negative
- None.
News Market Reaction – LH
In the Apr 1 session, LH gained 2.22%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 18 | Oncology collaboration | Positive | -1.8% | Expanded Illumina collaboration to broaden precision oncology testing access. |
| Feb 23 | Digital pathology deal | Positive | +0.9% | Expanded PathAI collaboration deploying FDA-cleared AISight Dx platform. |
| Feb 17 | Earnings and guidance | Positive | -2.1% | Reported strong 2025 results and 2026 guidance with higher EPS outlook. |
| Feb 11 | Alzheimer’s test launch | Positive | +1.9% | Nationwide launch of FDA-cleared pTau-181 blood test for Alzheimer’s assessment. |
| Feb 09 | Board appointment | Neutral | -1.1% | Appointed John H. Sampson, M.D., Ph.D., to Board of Directors. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent fundamentally positive news, including collaborations and strong 2025 results, has sometimes seen mixed or negative next-day price reactions.
Over recent months, Labcorp reported strong Q4 2025 and full-year results with $13.95B in revenue and adjusted EPS of $16.44, plus 2026 guidance calling for further growth. The company also advanced strategic initiatives, expanding collaborations with PathAI and Illumina and launching the first FDA-cleared blood test for Alzheimer’s assessment in primary care. Despite these positives, price reactions have been mixed, with some selloffs after good news. Today’s earnings-date announcement fits into a backdrop of ongoing innovation and partnerships ahead of formal Q1 2026 results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A replay of the webcast will be available on the "News & Events" section of the investor relations website approximately two hours after the conclusion of the live event and will be available for one year.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-announce-first-quarter-financial-results-on-april-30-2026-302730362.html
SOURCE Labcorp Holdings Inc